期刊文献+

荧光定量PCR检测传染性单核细胞增多症不同血样本EBV的研究

Assessment of Diagnostic Value with Real-time PCR for Measuring Epstein-Barr Virus Load in Whole Blood, Peripheral Mononuclear Cells and Plasma
在线阅读 下载PDF
导出
摘要 [目的]寻找荧光定量PCR检测传染性单核细胞增多症(IM)EBV DNA拷贝量的最佳样本。[方法]采用荧光定量PCR分别检测了IM病人的外周血单个核细胞、全血基因组DNA及血浆的EBV DNA拷贝量,并比较各种方法的阳性率及拷贝量。[结果]三种不同来源的样品荧光定量PCR方法的阳性率分别为76%、69%、23%。全基因组及单个核细胞组阳性率比较经x^2检验,差异无显著性,且两组拷贝量比较差异亦无显著性。血浆组阳性率及拷贝量与前两种方法比较差异均有显著性。[结论]外周血单个核细胞是荧光定量PCR检测IM的EBV DNA量的最佳样本。 [Objective]Epstein-Barr virus (EBV) DNA load monitoring in blood has been shown to be essential for the diagnosis of infectious mononucleosis. The aim of this study was to evaluate the relative diagnostic value of EBV DNA load monitoring in whole blood, peripheral blood mononuclear cells (PBMCs) and plasma by LightCycler(r) real-time quantitative PCR (LC-PCR). [Methods]First, 52 patients who suffered from infectious mononucleosis were diagnosed . Second, EBV DNA load was determined prospectively by LightCycler(r) real-time quantitative PCR (LC-PCR) in the whole blood, PBMCs and plasma . [Results] 76% .69% .23% samples were positive in PBMCs ,whole blood and plasma resepectively. EBV DNA load was 3.98±0. 64 log10copies/mL, 3.79±0.61 log10copies/mL ,2.71± 0.91 log10copies/mL resepectively . The frequency of positive EBV and the load was significantly different between PBMCs or whole blood and plasma P 〈0.05 ,but there was not significantly different between PBMCs and whole blood. P 〉0.05. [Conclusion] The quantitative detection of EBV DNA load in PBMCs and whole blood appeared more sensitive than in plasma for infectious mononucleosis. Because EBV DNA extraction was time-consumed, so PBMCs was the most feasible blood compartments for the early diagnosis of infectious mononucleosis.
出处 《医学临床研究》 CAS 2009年第2期289-291,共3页 Journal of Clinical Research
关键词 传染性单核细胞增多症 疱疹病毒4型 人/血液 聚合酶链反应 infectious mononucleosis herpesvirus 4,human/BL polymerase chain reaction
  • 相关文献

参考文献13

  • 1Pitetti RD, Laus S.Wadowsky RM. Clinical evaluation Qf a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children [J]. Pediatr Infect Dis J ,2003 Aug;22(8) :736-739.
  • 2Ikuta K, Saiga K, Deguchi M, Sairenji T. Epstein-Barr virus DNA is detected in peripheral blood mononuclear ceils of EBV-seronegative infants with infectious mononucleosis-like symptoms[J]. Virus Genes ,2003,26(2) : 165-173.
  • 3王晓莉,于洁.EB病毒感染及其相关性疾病[J].国外医学(儿科学分册),2005,32(5):287-290. 被引量:20
  • 4Fafi-Kremer S, Brengel-Pesce K, .Bargues G, et al . Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma[J]. J Clin Virol , 2004,30(2) :157-164.
  • 5Leung E, Shenton BK, Jackson G, et al . Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood [J]. J Immunol Methods ,2002,270(2) :259-267.
  • 6Niesters HG, van Esser J, Fries E, et al . Development of a real-time quantitative assay for detection of Epstein-Barr virus [J]. J Clin Microbiol ,2000,38(2):712-715.
  • 7Mouritsen CL, Wittwer CT, Reed G, at al. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR[J]. Biochem Mol Med ,1997,60(2):161-168.
  • 8Berger C, Day P, Meier G, et al . Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease[J]. J Med Virol ,2001,64(4) :505-512.
  • 9Wagner HJ, Jabs W, Smets F, et al . Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells[J]. Klin Padiatr ,2000,212(4) :206-210.
  • 10Kimura H, Hoshino Y, Hara S, et al. Viral load in Epstein- Barr virus-associated hemophagocytic syndrome [ J ]. Microbiol Immunol ,2002,46(8) :579-582.

二级参考文献15

  • 1Macsween KF, Crowford DH. Epstein-Barr virus-rescent advances[J]. Lancet Infect Dis,2003,3(3) : 131-140.
  • 2Jenson HB. Acute complications of Epstein-Barr virus infectious mononucleosis[J]. Curt Opin Pediatr,2000,12(3) :263-268.
  • 3Wood MJ. Vrial infections in neutropenia-current problems and chemotherapeutic control[J]. J Antimicrob Chemother, 1998,41 ( Suppl D) :81-93.
  • 4Weinstein M, O' Hare B. Hemoptysis and Epstein-Barr virus infection [ J ].Pediatr Infect Dis J ,2000, 19(8) :759-760.
  • 5Imashuhu S. Clinical features and treatment strategies of Epstein-Barr virus associated hemophagocytic lymphohistiocytosis[J]. Crit Rev Oncol Hematol ,2002,44(3) :259-272.
  • 6Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr cures in EBV-assceiated hemophagocytic lymphohistiocytosis and chronic active EBV infection [ J ]. Crit Rev Oncol Hematol, 2002,44 (3) : 283-294.
  • 7Savoldo B, Huls NH, Liu Z, et al. Autologons Epsteln-Barr virus specific cytotoxic T cells for the treatment of persistent active EBV infection [ J ].Blood, 2002,100(12) : 4095-4096.
  • 8Okano M, Gross TG. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders[J]. Am J Med Ssc,2000,319(6) : 392-396.
  • 9Schuster V, Kreth HW. X-linked lymphopmliferative disease is caused by deficiency of novel SH2 domain-containing signal transduction adaptor protein[ J ]. Immunol Rev, 2000,178 ( 1 ) : 21-28.
  • 10Hopwood P,Crawford DH.The role of EBV in post-transplant malignancies[J] .J Clin Pathol,2000,53(4) :248-254.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部